Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03103737
Other study ID # ONCOTIC-II
Secondary ID
Status Completed
Phase N/A
First received March 22, 2017
Last updated March 31, 2017
Start date January 2012
Est. completion date August 31, 2013

Study information

Verified date March 2017
Source University of Valencia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to test the efficacy of a brief psychological intervention composed by two therapeutic modules (virtual environments and reminiscence techniques) for the promotion of wellbeing of hospitalized adult cancer patients. Participants are randomly assigned to 2 conditions: intervention condition and control condition.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date August 31, 2013
Est. primary completion date August 31, 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adults with any cancer diagnosis

- hospitalized for at least 1 week

- Karnofsky functional state =50

- life expectancy =2 months

Exclusion Criteria:

- serious psychopathology

- cognitive impairment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Virtual Reality (VR) and Reminiscence Intervention
First and third sessions are dedicated to remember positive and meaningful personal experiences. Second and fourth sessions are oriented to positive emotions by the use of VR. Participants can choose the virtual environment to work with.

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
Rosa María Baños Rivera Hospital Clínica Benidorm, Universidad Politécnica de Valencia, Universitat Jaume I

Outcome

Type Measure Description Time frame Safety issue
Primary Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983; adapted version of Tejero, Guimerá, Farré & Peri, 1986) Change from baseline to 1 week
Primary Fordyce Happiness Scale (Fordyce, 1988). Change from baseline to 1 week
Secondary Visual Analog Scale: Mood. Subjective mood change after each session. 4 days along 1 week
Secondary Visual Analog Scale: Emotional State. Change pre-post sessions. positive affect, negative affect, well-being and calmness (5-point Likert scale) 4 days along 1 week
Secondary Visual Analog Scale: Physical Discomfort. Change pre-post sessions. fatigue, pain and nausea-vomiting (5-point Likert scale) 4 days along 1 week
Secondary Visual Analog Scale: Satisfaction with the Session pleasantness and perceived usefulness (5-point Likert scale) 4 days along 1 week
Secondary Satisfaction with Intervention Scale (adapted version of Borkovec and Nau's, 1972). satisfaction, recommendation, utility and discomfort (5-point Likert scale) 1 week
Secondary Distress Thermometer (Roth et al., 1998). Change from baseline to 1 week
Secondary Time perception (based on Bayés et al., 1997). Participants has to indicate the session duration (in minutes). An objective measure of the time lapse is also registered by the researcher. 4 days along 1 week
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases